KRYS
Krystal Biotech Inc
NASDAQ: KRYS · HEALTHCARE · BIOTECHNOLOGY
$262.26
+0.89% today
Updated 2026-04-30
Market cap
$7.65B
P/E ratio
38.06
P/S ratio
19.66x
EPS (TTM)
$6.83
Dividend yield
—
52W range
$123 – $298
Volume
0.3M
Krystal Biotech Inc (KRYS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.31M | $-3.89M | $-9.45M | $-18.71M | $-26.08M | $-47.94M | $-100.57M | $-88.80M | $123.42M | $200.87M |
| Capital expenditures | $15000.00 | $210000.00 | $2.23M | $6.40M | $14.84M | $68.34M | $52.98M | $11.80M | $4.24M | $11.95M |
| Depreciation | $2000.00 | $23000.00 | $141000.00 | $748000.00 | $1.85M | $2.77M | $4.05M | $5.01M | $6.71M | — |
| Stock-based comp | $33000.00 | $246000.00 | $792000.00 | $1.24M | $3.27M | $15.32M | $33.23M | $39.93M | $49.13M | $54.51M |
| Free cash flow | $-1.33M | $-4.10M | $-11.68M | $-25.11M | $-40.93M | $-116.27M | $-153.55M | $-100.60M | $119.18M | $188.91M |
| Investing cash flow | $-15000.00 | $-210000.00 | $-10.32M | $-4.97M | $-11.18M | $-226.77M | $-114.08M | $82.64M | $-163.44M | — |
| Financing cash flow | $3.25M | $51.77M | $73.85M | $107.53M | $118.02M | $347.69M | $35.35M | $202.75M | $27.01M | — |
| Dividends paid | — | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $47.67M | — | $83.84M | $80.75M | $72.98M | — | — | — | — |